Sutton Wealth Advisors Inc. - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sutton Wealth Advisors Inc. ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$16,484
-12.1%
371
-2.1%
0.01%
+16.7%
Q1 2022$18,757
-1.2%
379
+1.6%
0.01%0.0%
Q4 2021$18,993
-8.2%
373
+0.5%
0.01%
-25.0%
Q3 2021$20,694
+30.3%
3710.0%0.01%
+33.3%
Q2 2021$15,879
+2.5%
3710.0%0.01%0.0%
Q1 2021$15,486
-10.4%
3710.0%0.01%
-14.3%
Q4 2020$17,277
+9.6%
3710.0%0.01%
-12.5%
Q3 2020$15,760
-11.5%
3710.0%0.01%
-11.1%
Q2 2020$17,801
+4.3%
3710.0%0.01%
-18.2%
Q1 2020$17,066
-23.4%
3710.0%0.01%0.0%
Q4 2019$22,290
+6.2%
3710.0%0.01%
-8.3%
Q3 2019$20,987
+1.6%
3710.0%0.01%0.0%
Q2 2019$20,657
+10.3%
3710.0%0.01%
+9.1%
Q1 2019$18,732
+88.9%
371
+159.4%
0.01%
+83.3%
Q3 2018$9,914
+70.3%
143
+31.2%
0.01%
+50.0%
Q4 2017$5,823
+12.2%
109
+25.3%
0.00%0.0%
Q3 2017$5,189
-37.4%
87
-17.1%
0.00%
-42.9%
Q2 2017$8,283
-4.9%
1050.0%0.01%0.0%
Q1 2017$8,709
+4.5%
1050.0%0.01%0.0%
Q4 2016$8,331
+13.3%
1050.0%0.01%0.0%
Q3 2016$7,3501050.01%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders